.jpeg)
The Difference Between Adagrasib and Sotoracib
Adagrasib (Adagrasib) and sotorasib are both therapeutic drugs for KRAS G12C mutated non-small cell lung cancer (NSCLC) and belong to the same category of targeted therapy drugs. However, they have some differences in some aspects. Adagrasiib is a small molecule targeted drug whose mechanism of action is to inhibit the proliferation and survival of cancer cells by specifically interfering with abnormal cell signaling caused by KRAS G12C mutation. Sotorasib is also a small molecule targeted drug that acts on the KRAS G12C mutation and inhibits the growth of cancer cells by binding to the KRAS G12C mutated protein.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
